For example, for patients at a high risk of hyperkalaemia but low-average risk of hyponatremia initiating or switching to a thiazide-type diuretic rather than ACE inhibitors/angiotensin II receptor blockers is recommended. This evidence concerns the gene ACE and Hyponatremia.